Workflow
昭衍新药
icon
Search documents
港股收盘(12.09) | 恒指收跌1.29% 有色金属、芯片股承压 中国中冶(01618)重...
Xin Lang Cai Jing· 2025-12-09 08:57
Market Overview - The Hong Kong stock market indices declined again, with the Hang Seng Index falling 1.29% to 25,434.23 points and a total trading volume of HKD 210.236 billion [1] - The decline in the Hong Kong market is attributed to several factors, including a shrinking southbound capital flow, concerns over potential interest rate hikes by the Bank of Japan, and expectations that the Federal Reserve's upcoming rate cut may not be as dovish as anticipated [1] Blue Chip Performance - WuXi Biologics (02269) led the blue-chip stocks, rising 1.88% to HKD 33.56, contributing 3.64 points to the Hang Seng Index [2] - Other notable blue-chip performances included China Biologic Products (01177) up 1.33% and WuXi AppTec (02359) up 1.06%, while Xinyi Glass (00868) fell 8.11% and Chow Tai Fook (01929) dropped 4.82% [2] Sector Movements - Large technology stocks experienced declines, with Alibaba down 1.63% and Tencent down 0.41%. Chip stocks fell collectively after the announcement allowing NVIDIA to sell H200 chips to China, with SMIC down over 4% [3][5] - The real estate sector saw significant declines, particularly with Agile Group (03383) dropping 18.42% amid a court liquidation petition [4] - Industrial metals stocks, including Jiangxi Copper (00358) and China Aluminum (02600), faced notable declines, with Jiangxi Copper down 6.51% [3][4] Notable Company Developments - China Metallurgical Group (01618) saw a significant drop of 21.01% after announcing a cash transaction to sell its subsidiaries for approximately HKD 60.7 billion [6] - Gilead Sciences (01672) surged 18% following positive results from a clinical trial for its obesity treatment, with Citigroup expecting a positive market reaction [7] - E-Hi Auto (02858) rose 10.67% after renewing a strategic cooperation agreement with Tencent's subsidiary for used car services [8]
港股收盘(12.09) | 恒指收跌1.29% 有色金属、芯片股承压 中国中冶(01618)重挫21%
智通财经网· 2025-12-09 08:54
市场等待本周美联储议息会议,港股三大指数今日再度走低,恒指及国指均跌超1%,恒科指数一度跌 超2%。截止收盘,恒生指数跌1.29%或331.13点,报25434.23点,全日成交额为2102.36亿港元;恒生国 企指数跌1.62%,报8936.41点;恒生科技指数跌1.9%,报5554.68点。 中金指出,关于近期港股为何在三地中走得更弱,资金面上可以找到一些解释:1)南向过去几周持续 萎缩,港股不在基准的话可能导致调仓;对比之下,港股IPO 一点不少,且上半年集中上市的大票纷纷 到了6个月解禁期;2)日央行下周加息担忧挥之不去;3)美联储本周虽然降息,但觉得也很难鸽派, 所以美债利率不降反升,诸如此类。 蓝筹股表现 药明生物(02269)领涨蓝筹。截至收盘,涨1.88%,报33.56港元,成交额14.34亿港元,贡献恒指3.64点。 交银国际指,2025年CXO整体订单和业绩复苏势头明显。该行预计,随着下游融资边际改善+出海热潮 带动上游景气度逐步进一步回升,2026年板块有望维持较快的业绩增速。但在美国药品相关监管收紧、 新药研发难度升级的长期大趋势下,行业整合或才刚拉开序幕,未来将继续淘汰落后产能及企业 ...
港股收盘 | 恒指收跌1.29% 有色金属、芯片股承压 中国中冶重挫21%
Zhi Tong Cai Jing· 2025-12-09 08:51
1. 有色金属股跌幅居前。截至收盘,江西铜业(600362)股份(00358)跌6.51%,报33.58港元;洛阳钼业 (603993)(03993)跌6.42%,报17.92港元;中国铝业(601600)(02600)跌5.69%,报10.77港元;紫金矿 业(601899)(02899)跌4.24%,报32.5港元。 盘面上,大型科技股悉数下跌,阿里巴巴跌1.63%,腾讯跌0.41%。特朗普宣布允许英伟达对华出售 H200芯片,芯片股集体走低,中芯国际跌超4%,数据中心股万国数据则涨超2%;内房股普遍下行,雅 居乐集团跌超18%;水泥、钢铁、石油、航空股等承压。另一边,部分医药股逆势走强,歌礼制药 ASC30治疗肥胖症的13周II期研究取得积极顶线结果,股价劲升18%。 市场预计日本央行将调整加息步伐;欧洲央行执委Schnabel的鹰派讲话,促使市场押注明年加息;美联 储影子主席哈塞特发表的不够鸽派的言论,同样打压明年降息预期。分析人士指出,市场几乎已消化美 联储本周降息的预期,但投资者认为其政策声明和主席鲍威尔的讲话可能暗示进一步降息的门槛提高。 市场等待本周美联储议息会议,港股三大指数今日再度走低,恒 ...
三大指数同步回调 部分医药与算力股逆市飘红
Xin Lang Cai Jing· 2025-12-09 08:40
智通财经12月9日讯(编辑 胡家荣)今日港股市场表现疲弱,三大指数全线收跌。截至收盘,恒生指数跌1.29%,报25434.23点;恒生科技指数跌1.90%,报 5554.68点;国企指数跌1.62%,报8936.41点。 注:恒生指数的表现 尽管当前港股市场持续承压,但是招商证券指出,2026年港股核心驱动力将转向"新供给创造新需求"的新范式。这一转变源自科技创新加速、产业转型升级 以及财政模式优化,为市场提供坚实支撑。叠加中美流动性双宽松环境与当前估值洼地优势,他们预测恒生指数2026年有望实现10%-15%的温和上行,呈 现"慢牛"格局。 截至收盘,江西铜业股份(00358.HK)跌6.51%、洛阳钼业(03993.HK)跌6.42%、中国铝业(02600.HK)跌5.69%。 | 代码 | 名称 | 最新价 | 涨跌额 | 涨跌幅 * | | --- | --- | --- | --- | --- | | 00661 | 中国大冶有色金属 | 0.093 | -0.010 | -9.71% | | 00358 | 江西铜业股份 | 33.580 | -2.340 | -6.51% | | 03993 | ...
港股收评:恒指跌1.29%、科指跌1.9%,科网股、芯片股及新消费概念股集体走低
Jin Rong Jie· 2025-12-09 08:21
Market Overview - The Hong Kong stock market experienced a volatile trading day on December 9, with the Hang Seng Index closing down 1.29% at 25,434.23 points, the Hang Seng Tech Index down 1.90% at 5,554.68 points, and the National Enterprises Index down 1.62% at 8,936.41 points [1] - Technology stocks generally declined, with notable drops in Bilibili, Xiaomi, and Baidu, each falling over 3%, while Kuaishou and Meituan dropped over 2% [1] - Gold and non-ferrous metal stocks faced pressure, with Zijin Mining down over 4% [1] - Real estate stocks weakened significantly, with Yaloo Group plunging over 18% [1] - The semiconductor sector saw substantial declines, with Huahong Semiconductor down over 5% and SMIC down over 4% [1] - New consumption concept stocks also fell, with Pop Mart down over 5% [1] - Pharmaceutical stocks performed well, with Genscript Biotech rising 18%, Hongteng Precision up 11%, and Zhaoyan New Drug up 5.9% [1] Company News - Dongfeng Group reported cumulative sales of 1.697 million vehicles in the first 11 months, a slight decrease of approximately 0.3% year-on-year, while new energy vehicle sales reached 489,203 units, marking a 39.1% increase [2] - New天绿色能源 achieved a cumulative power generation of 13.3689 million MWh in the first 11 months, an increase of 8.04% year-on-year, with November's generation at 1.662 million MWh, up 24.45% [2] - Longyuan Power completed a cumulative power generation of approximately 69.0964 million MWh in the first 11 months, reflecting a year-on-year growth of 0.41% [2] - Greenland Hong Kong reported contract sales of approximately 6.823 billion yuan in the first 11 months, a decline of 22.6% year-on-year [3] - Sunny Optical Technology completed a share swap merger with GoerTek, with its subsidiary Ningbo Aolai holding approximately 31.31% of the shares, becoming the second-largest shareholder [3] - Zoomlion Heavy Industry completed the acquisition of 81% of the shares in Zoomlion Heavy Industry Finance Leasing (Beijing) [4] - Cambridge Technology plans to increase its investment in CIG USA by $100 million [5] - WuXi AppTec announced research data for JWCAR201 IIT at the 67th American Society of Hematology Annual Meeting [6] - Four Seasons Pharmaceutical's innovative drug Anjiuwei® was successfully renewed for inclusion in the 2025 National Basic Medical Insurance Drug List, while its innovative drug Xuanyue Ning® was included for the first time [6] - Yuan Da Pharmaceutical's Class 1 innovative drug GPN01360 successfully reached clinical endpoints in a Phase II clinical study conducted in China [7] - Agile Group's hearing has been further postponed to March 9, 2026 [8] Institutional Insights - Bank of China International views the recent market adjustment as a normal phenomenon in a bull market, maintaining a positive outlook for the Hong Kong stock market, predicting the Hang Seng Index could reach 30,100 points by December 2026 [9] - Huaxia Fund believes that the previous irrational panic in the tech sector has eased, and with AI development paths becoming clearer, it is advisable to position for a recovery in the market [9] - Everbright Securities notes that the Hang Seng Index's current P/E ratio is above its five-year average, indicating a reasonable valuation range, while the tech index has room for growth [9] - Guosen Securities suggests that the recent market adjustment opens up space for future growth, with significant net inflows from southbound funds into the Hong Kong market [10]
【新华500】新华500指数(989001)12月9日跌0.50%
Xin Hua Cai Jing· 2025-12-09 07:32
走势上看,新华500指数(989001)9日震荡回落。指数盘中最高触及5103.07点,最低触及5053.40点,成分股全天总成交额报6162亿元。 成分股方面,永辉超市涨9.95%,生益科技、工业富联、昭衍新药涨幅居前。中国中冶跌10.03%领跌成分股,科利达、洛阳钼业等成分股跌幅靠前。 新华财经北京12月9日电(王媛媛)新华500指数(989001)12月9日收盘报5069.02点,跌幅0.50%。 (文章来源:新华财经) ...
昭衍新药盘中一度涨停
Bei Jing Shang Bao· 2025-12-09 05:25
Core Viewpoint - On December 9, Zhaoyan New Drug (603127) experienced a significant increase in stock price, reaching a peak of 30.77 yuan per share, indicating strong market interest and potential investor confidence [1] Group 1: Stock Performance - On December 9, Zhaoyan New Drug opened with a 1.89% increase and saw its stock price fluctuate, eventually hitting the daily limit up [1] - The stock closed at 30.03 yuan per share, reflecting a 7.37% increase by the time of reporting [1]
港股午评 恒生指数早盘跌0.84% 光通信概念股再度上扬
Jin Rong Jie· 2025-12-09 05:10
Group 1: Market Overview - The Hang Seng Index fell by 0.84%, down 215 points, closing at 25,549 points, while the Hang Seng Tech Index dropped by 1.32% [1] - The early trading volume in the Hong Kong stock market reached HKD 107.8 billion [1] Group 2: Optical Communication Sector - Optical communication stocks surged again, driven by the demand for high-speed optical transceiver modules due to AIDC development, with institutions predicting a significant increase in shipment volume next year [1] - Notable stock performances include: - Hong Teng Precision (06088) up 7.95% - Changfei Optical Fiber (06869) up 4.57% - Cambridge Technology (06166) up 3.06% - Huiju Technology (01729) up 0.53% [1] Group 3: New Listings and Innovations - Zhuoyue Ruixin (02687) saw a rise of over 16% on its second day of trading, with its price increasing 120% from the IPO price, approaching a total market value of HKD 10 billion; the company specializes in digital solutions for higher education institutions [1] - Bai Ao Sai Tu-B (02315) increased by over 8%, reaching a new high, as it prepares to enter the A-share Sci-Tech Innovation Board [1] - Zhaoyan New Drug (06127) rose by over 8% due to a surge in the price of experimental monkeys, with institutions indicating a potential widening supply-demand gap [1] Group 4: Oil Sector Performance - Oil stocks collectively declined as geopolitical events weakened support for oil prices, although institutions remain optimistic about the long-term investment value of the three major oil companies [1] - Notable declines include: - PetroChina (00857) down 3% - Sinopec (00386) down 2.21% - CNOOC (00883) down 2.32% [1] Group 5: Non-Ferrous Metals Sector - Non-ferrous metal stocks experienced significant declines, influenced by market focus on the future interest rate policies of various central banks [2] - Key stock performances include: - Jiangxi Copper (00358) down 5.96% - Luoyang Molybdenum (03993) down 6.27% - China Aluminum (02600) down 5.34% [2] Group 6: Other Notable Declines - Silver Noble Pharmaceutical-B (02591) fell by over 14%, with a cumulative decline of 25% since entering the market [2] - Ocean Park Hong Kong (02255) dropped by 9%, hitting a new low for the year amid financial product repayment issues faced by its controlling shareholder [3]
刚刚,利好来袭!盘中,直线猛拉!
中国基金报· 2025-12-09 05:04
Market Overview - The A-share market showed mixed performance on December 9, with the Shanghai Composite Index down 0.13% at 3918.83 points, while the Shenzhen Component rose 0.09% and the ChiNext Index increased by 1.07% [2] - The total trading volume in the Shanghai and Shenzhen markets was 1.26 trillion yuan, a decrease of 34.7 billion yuan compared to the previous trading day, with 1738 stocks rising and 3555 stocks falling [4] Sector Performance - The optical module (CPO) sector continued to rise, along with innovative pharmaceuticals, consumer electronics, and retail stocks, while precious metals and real estate sectors lagged [5] - The CPO concept achieved a four-day consecutive rise, with stocks like Zhongji Xuchuang and Tianfu Communication reaching new highs [10] - The innovative pharmaceutical sector was active, with Hai Chuang Pharmaceutical rising over 13% and Zhao Yan New Drug increasing over 8% [18] - The consumer electronics sector saw significant activity, with stocks like Dahua Intelligent and Furuon Technology hitting the daily limit [22] - The commercial retail sector experienced a strong surge, with multiple stocks such as Central Plaza and Yonghui Supermarket reaching the daily limit [27] Notable Stocks - Zhongji Xuchuang rose by 6.94% to 609.58 yuan per share, with a market capitalization of 677.3 billion yuan [11] - Hai Chuang Pharmaceutical reached 53.75 yuan per share, up 13.13%, with a market capitalization of 5.3 billion yuan [19] - Dahua Intelligent recorded a 9.96% increase to 7.84 yuan per share, with a market capitalization of 8.7 billion yuan [24] - Central Plaza saw a 10.03% rise to 4.06 yuan per share, with a market capitalization of 4.6 billion yuan [28] News Impact - The National Medical Insurance Drug List for 2025 was released, adding 114 new drugs, with a success rate of 88%, significantly higher than the previous year's 76% [20] - Google's recent launch of the AndroidXR-themed smart glasses in collaboration with XREAL is expected to impact the consumer electronics market [25] - The U.S. government announced that NVIDIA would be allowed to sell its H200 AI chips to China, which may influence the semiconductor sector [34]
利好突袭!大涨
Zhong Guo Ji Jin Bao· 2025-12-09 04:37
| 跌3091 | 涨2149 | | --- | --- | | 成交额6181亿 | 预测成交额1.92万亿,缩1270亿 | 12月9日开盘,A股市场震荡拉升,创业板指涨逾1%,沪指跌0.03%,深成指涨0.35%。 | 上证指数 | 深证成指 | 北证50 | | --- | --- | --- | | 3922.79 | 13376.53 | 1418.57 | | -1.28 -0.03% | +46.54 +0.35% | -7.68 -0.54% | | 科创50 | 创业板指 | 万得全A | | 1353.91 | 3224.50 | 6322.00 | | +3.12 +0.23% | +34.23 +1.07% | +6.53 +0.10% | | 沪深300 | 中证500 | 中证A500 | | 4624.80 | 7179.66 | 5564.18 | | +3.05 +0.07% | +7.29 +0.10% | +2.81 +0.05% | | 中证1000 | 深证100 | 中证红利 | | 7437.69 | 5895.60 | 5502.05 | | +14.65 ...